Erectile dysfunction drugs were associated with reduced risk of Alzheimer's disease, electronic health record (EHR) data from 270,000 men in the U.K. suggested. Over a median follow-up of about 5 ...

CHICAGO -- The two most popular medications for erectile dysfunction (ED) may confer substantial cardiovascular benefits for men with ED and concurrent heart disease, according to an analysis of a ...

Men with stable CAD who are being treated for erectile dysfunction (ED) have a lower risk of dying if their medication is a phosphodiesterase 5 (PDE5) inhibitor rather than alprostadil, observational ...

Men taking phosphodiesterase type 5 (PDE5) inhibitors for erectile dysfunction (ED) have lower risks of overall MACE, cardiovascular mortality, and all-cause mortality than those not on these ...

Please provide your email address to receive an email when new articles are posted on . Men with CAD who combined nitrates with common ED drugs were at higher risk for death and adverse CV events. The ...